Championing a Smoke-Free World 2024 First-Quarter Results April 23, 2024 Introduction • A glossary of terms as well as adjustments, other calculations and reconciliations to the most directly comparable U.S. GAAP measures for non-GAAP financial measures cited in this presentation are available in Exhibit 99.2 to the company's Form 8-K dated April 23, 2024 and on our Investor Relations website with additional non- GAAP reconciliations available at the end of this presentation 2 -- 1 of 16 -- Forward-Looking and Cautionary Statements • This presentation contains projections of future results and goals and other forward-looking statements, including statements regarding expected financial or operational performance; capital allocation plans; investment strategies; market expectations; dividends. Achievement of future results is subject to risks, uncertainties and inaccurate assumptions. In the event that risks or uncertainties materialize, or underlying assumptions prove inaccurate, actual results could vary materially from those contained in such forward-looking statements. Pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, PMI is identifying important factors that, individually or in the aggregate, could cause actual results and outcomes to differ materially from those contained in any forward-looking statements made by PMI • PMI's business risks include: excise tax increases and discriminatory tax structures; increasing marketing and regulatory restrictions that could reduce our competitiveness, eliminate our ability to communicate with adult consumers, or ban certain of our products in certain markets or countries; health concerns relating to the use of tobacco and other nicotine-containing products and exposure to environmental tobacco smoke; litigation related to tobacco and / or nicotine use and intellectual property; intense competition; the effects of global and individual country economic, regulatory and political developments, natural disasters and conflicts; the impact and consequences of Russia's invasion of Ukraine; changes in adult smoker behavior; the impact of natural disasters and pandemics on PMI's business; lost revenues as a result of counterfeiting, contraband and cross-border purchases; governmental investigations; unfavorable currency exchange rates and currency devaluations, and limitations on the ability to repatriate funds; adverse changes in applicable corporate tax laws; adverse changes in the cost, availability, and quality of tobacco and other agricultural products and raw materials, as well as components and materials for our electronic devices; and the integrity of its information systems and effectiveness of its data privacy policies. PMI's future profitability may also be adversely affected should it be unsuccessful in its attempts to introduce, commercialize, and grow smoke-free products or if regulation or taxation do not differentiate between such products and cigarettes; if it is unable to successfully introduce new products, promote brand equity, enter new markets or improve its margins through increased prices and productivity gains; if it is unable to expand its brand portfolio internally or through acquisitions and the development of strategic business relationships; if it is unable to attract and retain the best global talent, including women or diverse candidates; or if it is unable to successfully integrate and realize the expected benefits from recent transactions and acquisitions. Future results are also subject to the lower predictability of our smoke-free business’ performance • PMI is further subject to other risks detailed from time to time in its publicly filed documents, including PMI’s Annual Report on Form 10-K for the fourth quarter and year ended December 31, 2023 and the Form 10-Q for the quarter ended March 31, 2024, which will be filed in the coming days. PMI cautions that the foregoing list of important factors is not a complete discussion of all potential risks and uncertainties. PMI does not undertake to update any forward-looking statement that it may make from time to time, except in the normal course of its public disclosure obligations 3 Very Strong Q1 Performance 4 • Outstanding growth in currency-neutral net revenues, operating income & adj. EPS: ⎼ Strong IQOS and ZYN momentum continues with smoke- free organic net revenues +25% and gross profit +38% ⎼ Excellent adjusted OI growth and margin expansion on both organic and dollar basis • Actions to mitigate increased currency headwinds • Impressive Q1 sets the stage to deliver strong year of growth in both constant currency and USD Source: PMI Financials or estimates -- 2 of 16 -- Note: Growth rates presented on an organic basis reflect currency-neutral adjusted results. Shipment volume includes HTUs, cigarettes and oral SFP excluding snuff, snuff leaf and U.S. chew. Source: PMI Financials or estimates Q1, 2024: Excellent Start to the Year 5 Organic Growth Adj. Growth incl. Currency Adj. Diluted EPS (Variance vs. PY) +23.2 % +8.7 % +22.2 % Operating Income (Variance vs. PY) +11.3 % Net Revenues (Variance vs. PY) +11.0 % +8.6 % Shipment Volume (Variance vs. PY) +3.6 % (a) Volumes shown in pouches or pouch equivalent, excluding snuff, snuff leaf and U.S. chew. Note: Total may not foot due to rounding Source: PMI Financials or estimates Volume Growth Driven by Smoke-Free Products 6 (shipments, billion units) Oral SFP(a) Q1’24 Q1’23 143.2 33.1 4.2 +35.8% +20.9% (0.4)% +3.6% Change vs. PY Adj. IMS Change vs. PY +12.5% +0.2% HTUs Cigarettes Total 174.2 180.5 143.7 27.4 3.1 +22.4% Smoke-Free Shipments -- 3 of 16 -- Top-Line Growth Powered by Volumes, Pricing & Category Mix 7 (a) Represents Smoke-Free Business Note: Smoke-free mix represents the impact of an increased proportion of smoke-free products at higher net-revenue per unit and is calculated at total PMI level, excluding the impact from market mix. Source: PMI Financials or estimates Q1'24 Organic Shipment Volume Organic Net Revenue Growth Q1'24 Adj. Net Revenue Growth +8.6% Pricing (Combustibles & Smoke-Free(a)) +11.0% Currency +3.6% +3.1pp +5.5pp Smoke-Free Mix Impact (2.4)pp (1.2)pp Geographic Mix & Other +2.2pp Oral SFP Organic OI Growth Driven by Excellent Smoke-Free Accretion 8 (a) Represents Smoke-Free Business. Note: Organic smoke-free gross margin growth is calculated based on organic smoke-free gross profit, divided by organic smoke-free net revenues. Chart not to scale. Growth rates presented on an organic basis reflect currency-neutral adjusted results. Source: PMI Financials or estimates Net Revenues Gross Profit Operating Income 13.7% 11.0% Total PMI Net Revenues Gross Profit 37.5% Smoke-Free(a) Combustibles 2.3% Q1’24 Organic Variance vs. PY Net Revenues Gross Profit 22.2% 24.8% 3.7% +600bps Smoke-Free Gross Margin -- 4 of 16 -- Q1'23 Q1'24 SG&A Gross Margin 41.0% Currency Gross Margins and SG&A Driving Strong OI Margin Expansion 9 Source: PMI Financials or estimates 37.3% Adjusted OI Margin 38.2% +1.5pp +2.2pp (2.8)pp Q1’24 (excl. Currency) Currency +90 bps Adj. OI Margin Broad-Based Margin Expansion Across Regions 10 Source: PMI Financials or estimates Organic Adj. OI Margin (Q1’24, Change vs. PY, pp) Adj. OI Margin (Q1’24, Change vs. PY, pp) Total PMI Europe SSEA, CIS & MEA EA, AU & PMI DF Americas Total PMI Europe EA, AU & PMI DF Americas 3.1 2.4 6.4 3.2 3.7 (4.1) 2.5 2.2 4.5 0.9 SSEA, CIS & MEA -- 5 of 16 -- PMI HTUs: Second-Largest ‘Brand’ in IQOS Markets 11 (a) Reflects 72 markets (including Indonesia, following broader commercialization in the market) where IQOS is available in key cities or nationwide at March 31, 2024 Note: All ‘brands’ except ‘PMI HTUs’ include cigarettes only. Reflects PMI in-market sales volume as a percentage of total estimated sales volume for cigarettes and HTUs, including cigarillos in Japan. Source: PMI Financials or estimates 10.2% 8.4% 3.5% Marlboro Winston PMI HTUs L&M Share in IQOS Markets (Q1’24)(a) Camel Gudang Garam 11.8% 10.3% Excluding Indonesia IQOS #1 ‘Brand’ 11 Markets #2 Cleopatra 9.3% 9.0% 8.6% 9.7% Q1 Q2 Q3 Q4 Q1 11.1 11.6 12.0 12.4 12.6 Europe: Continued Growth to Surpass 10% Share Milestone 12 (a) Excluding the impact of estimated distributor and wholesaler inventory movements, based on a four-quarter moving average; (b) Adjusted market share for HTUs is defined as the total in-market sales volume for PMI HTUs as a percentage of the total estimated sales volume for cigarettes and HTUs, excluding the impact of estimated distributor and wholesaler inventory movements; Source: PMI Financials or estimates HTU Adjusted SoM(b) Adj. IMS(a) (in billion units) 2023 2024 10.2% -- 6 of 16 -- Impressive Progress in European Key Cities 13 (a) Madrid represents municipality of Madrid (versus data previously presented on province of Madrid) and includes approximately half of the estimated 1.5 million Legal Age Nicotine Users in the province. Historical data: Q2’23 6.3%, Q3’23 6.0%, Q4’23 7.4% Note: Athens represents Attica Region. Source: PMI Financials or estimates 5.8% 6.4% 7.8% 8.2% 8.4% 12.3% 16.3% 20.1% 21.6% 22.4% 25.7% 28.7% 30.2% 31.6% 39.7% Amsterdam Stockholm Madrid London Vienna Munich Bucharest Zurich Warsaw Prague Lisbon Bratislava Rome Athens Budapest +0.8pp +0.7pp +1.8pp +1.0pp +1.4pp PMI HTU Offtake Share (Q1’24) +0.7pp Change vs. PY +1.3pp +1.4pp +2.9pp +4.6pp +4.6pp +4.3pp +3.2pp +1.6pp +4.4pp (a) Japan: Delivering Excellent Growth Through Innovation 14 (a) Excluding the impact of estimated distributor and wholesaler inventory movements, based on a four-quarter moving average; (b) Adjusted market share for HTUs defined as the total in-market sales volume for PMI HTUs as a percentage of total estimated sales volume for cigarettes, HTUs and cigarillos and excluding the impact of estimated distributor and wholesaler inventory movements; (c) Based on 3 C-Store Chains offtake. Base includes cigarettes, cigarillos and HTUs Source: PMI Financials or estimates 26.2% 26.3% 26.6% 27.5% 29.3% Q1 Q2 Q3 Q4 Q1 HTU Adjusted SoM(b) Adj. IMS(a) (in billion units) Japan HTU Offtake Share(c) Q1’23 Q1’24 Sendai +2.5pp 33.3% 30.8% Tokyo 35.1% 32.4% +2.7pp Fukuoka +3.7pp 32.6% 28.9% 2023 2024 9.0 9.3 9.6 9.9 10.2 -- 7 of 16 -- Premium Innovation Driving IQOS & HnB Category 15 2015 2019 2021 2023 2017 Combustibles Tokyo Monthly Offtake Category Share(a) (a) Based on 3 C-Store Chains offtake. Base includes cigarettes, cigarillos and HTUs Source: PMI Financials or estimates HTUs Mar’24 50.8% 49.2% 20.4% 8.8% 29.9% 0% 5% 10% 15% 20% 25% 30% Japan HTU Offtake Share(a) Total PMI TEREA SENTIA 2021 2022 2023 2024 16 2.8% 3.3% 3.4% 3.4% 4.6% 9.1% 10.3% 11.3% 12.8% 13.9% 16.1% 17.6% 19.0% Toronto Tunis Manila Urban Jakarta Rabat Cairo Santo Domingo Kuala Lumpur Seoul Belgrade Sofia Beirut Podgorica +1.6pp +1.3pp +1.8pp +0.9pp PMI HTU Offtake Shares (Q1’24) +1.8pp Change vs. PY +0.5pp +6.6pp +3.4pp +0.1pp +0.8pp +2.8pp Note: Urban Jakarta represents West, Central and South Jakarta which include an estimated 1.5 million Legal Age Nicotine Users. Cairo represents Urban Cairo, Manila represents Metro Manila, Tunis represents Greater Tunis. TEREA images of clove taste variants in Indonesia. Source: PMI Financials or estimates +1.0pp Promising Key City Growth Across Global Markets +0.6pp New TEREA Clove variants launched -- 8 of 16 -- Source: PMI Financials or estimates, Circana, LLC, Nicotine Pouches, Week ending 3/31/24 6 8 10 13 17 25 35 50 69 84 103 114 126 143 157 174 187 203 220 238 261 292 334 385 443 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 2018 2019 2020 2021 2022 ZYN Growth Momentum Continues 17 ZYN U.S. Shipment Volumes (12 months rolling, million cans) 79.3% Q1’24 Category Retail Value Share (13-week period) Category Volume Share (in %, 13-week period) 2023 2024 66.7 67.8 66.6 67.3 67.3 67.4 68.4 71.0 73.0 74.3 Combustibles: Strong Pricing and Category Share Growth 18 (a) Pricing variance is based on adjusted net revenues (b) Excludes China and the U.S. Reflects in-market sales volume of PMI cigarettes as a percentage of cigarette industry sales volume and includes cigarillos in Japan Source: PMI Financials or estimates Share of Cigarette Category(b) (Change vs. PY in pp) (0.7) 0.2 0.2 0.3 2021 2022 2023 Q1’24 2.7 5.0 8.9 7.9 2021 2022 2023 Q1'24 Combustible Pricing (% organic change vs. PY)(a) +0.4pp Marlboro Q1’24 Share of Category vs. PY -- 9 of 16 -- Accelerating & Expanding Our Smoke-Free Journey • ILUMA i launched in Japan • HTU portfolio expansion • Preparing IQOS U.S. pilots • International ZYN roll-out continues • Focused strategy for VEEV showing promising results 19 Raising 2024 Growth Forecasts on Strong Fundamentals 20 FY 2024 Outlook Updated Previous 14-16 % 14-16 % HTU Adj. IMS Growth >140 bn >140 bn HTU Shipment Volumes ~560 m ~520 m U.S. ZYN Shipment Volume (cans) 7-8.5 % 6.5-8 % Net Revenue Growth(a) 10-12 % 8-9.5 % Adj. OI Growth (a) 9-11 % 7-9 % Adj. Diluted EPS Growth(b) (a) On an organic basis (b) Currency-neutral variance Source: PMI Financials or estimates • Stronger outlook on underlying momentum and actions to address currency headwinds ⎼ Adj. diluted EPS $6.19 - $6.31, including unfavorable currency impact of 36 cents at prevailing exchange rates • Continue to target close to $15bn in smoke-free net revenues, with SFP driving majority of OI growth • Strong H1 expected on volumes, top-line growth and margin expansion: ⎼ Q2 Adj. diluted EPS of $1.50 - $1.55, including unfavorable currency impact of 14 cents at prevailing exchange rates • Ongoing progress on deleveraging balance sheet -- 10 of 16 -- Sustainability: Business Transformation Metrics Aspirations 2023 2022 2021 2015 100 by 2025 84 73 71 7 Number of markets where smoke-free products are available for sale*(a) ~60 by 2030 25 17 10 - Number of markets where adjusted net revenues from smoke- free products exceed 50% of adjusted total net revenues* ~40 by 2030 3 - - - Number of markets where adjusted net revenues from smoke- free products exceed 75% of adjusted total net revenues* >50% by 2025 47% 42% 42% 17% Proportion of markets where smoke-free products are available for sale that are low- and middle-income markets*(a) 74% 74% 73% 8% Commercial expenditure (Marketing) (smoke-free/total)* (27.9)% (26.8)% (26.4)% n/a Change in combustible tobacco product shipment volume (billion units) vs. 2015 baseline*(a) 99% 99% 99% 70% R&D expenditure ratio *(a) (smoke-free/total) 41% 43% 35% n/a Supply chain direct spend(a) (smoke-free/total) 16 out of 50 14 out of 49 9 out of 39 3 out of 48 Number of factories producing smoke-free products out of total number of factories *(a) 21 (a) See Appendix. Note: Select Business Transformation Metrics displayed. The 2023 metrics marked with an asterisk (*) are subject to PwC’s Limited Assurance Report, available on PMI Integrated Report 2023, pp. 203-205. R&D expenditure and Net Revenues shown on an adjusted basis; Source: PMI Financials or estimates Sustainability: Transparent Performance Reporting 22 PMI was included for the first time in the Dow Jones Sustainability World Index, and for the fourth consecutive year in the Dow Jones Sustainability North America Composite Index (Indices effective as of December 18, 2023). PMI achieved industry leadership, improving to a rating of “C+” in ISS ESG Corporate Rating and gaining “Prime” status” for the first time (score as of November 21, 2023) Source: PMI Integrated Report 2023 Sustainability resources -- 11 of 16 -- On Track for Strong 2024 Performance 23 • Strong IQOS and ZYN momentum, accelerated top- line and margin expansion • Excellent start to the year, raising full-year currency- neutral growth outlook • Focused on delivering USD performance, mitigating currency headwinds • Confident in 2024-26 targets, with ambition to reach >2/3 smoke-free net revenues by 2030 • Highly cash generative with focus on rapid deleveraging • Steadfast commitment to progressive dividend policy Source: PMI Financials or estimates Championing a Smoke-Free World Questions & Answers iOS Download Android Download Have you downloaded the PMI Investor Relations App? The free IR App is available to download at the Apple App Store for iOS devices and at Google Play for Android mobile devices Or go to: www.pmi.com/irapp 2024 First-Quarter Results -- 12 of 16 -- Championing a Smoke-Free World 2024 First-Quarter Results April 23, 2024 Championing a Smoke-Free World Appendix and Reconciliation of Non-GAAP Measures 26 -- 13 of 16 -- (a) See impairment and exit costs section in Earnings Release for details (b) See forecast assumptions in Earnings Release for details Source: PMI Financials or estimates 2024: EPS Guidance Growth 2023 2024 Forecast $5.02 $5.70 – $5.82 Reported Diluted EPS Adjustments: 0.06 0.09 - Asset impairment and exit costs (a) 0.04 - - Termination of distribution arrangement in the Middle East 0.44 0.01 - Impairment of goodwill and other intangibles 0.25 0.43 - Amortization of Intangibles(b) 0.03 - - Charges related to the war in Ukraine 0.01 - - Swedish Match AB acquisition accounting related item (0.11) 0.07 - Income tax impact associated with Swedish Match AB financing 0.11 - - South Korea indirect tax charge 0.07 - - Termination of agreement with Foundation for a Smoke-Free World (0.02) (0.08) - Fair value adjustment for equity security investments 0.11 (0.03) - Tax items 0.99 0.49 - Total Adjustments $6.01 $6.19 – $6.31 Adjusted Diluted EPS (0.36) - Less: Currency 9.0% –11.0% $6.01 $6.55 – $6.67 Adjusted Diluted EPS, excluding currency Full-Year ($/share) 27 Growth vs. PY Q1’24 Growth vs. PY Q1’24 Growth vs. PY Q1’24 +0.3pp 8.6% Romania +4.0pp 33.1% Hungary +1.6pp 8.6% Austria +0.1 17.5 Slovak Republic +0.9 17.7 Italy +0.7 8.9 Croatia +2.3 15.1 Slovenia +1.6 29.4 Lithuania +0.6 15.6 Czech Republic +1.5 12.8 Switzerland (0.4) 9.0 Poland +0.9 6.3 Germany +1.1 4.5 United Kingdom +4.1 23.4 Portugal +2.8 23.5 Greece 28 Europe: PMI HTU Adjusted Share of Market(a) (a) Adjusted market share for HTUs is defined as the total in-market sales volume for PMI HTUs as a percentage of the total estimated sales volume for cigarettes, HTUs and excluding the impact of estimated distributor and wholesaler inventory movement; Note: Select markets where HTU share is ≥ 1%; Source: PMI Financials or estimates -- 14 of 16 -- Business Transformation Metrics - Glossary • Unless otherwise stated, all applicable business transformation metrics include Swedish Match related data as of November 11, 2022 (acquisition date), as well as Vectura Fertin Pharma. In 2023, we evaluated and republished a new set of aspirations for 2030 to ensure they remain ambitious, reasonable, and achievable in the context of a dynamic and evolving smoke-free industry, and impacts of our recent acquisitions. • For definition of available for sale, see PMI Integrated Report 2023 Glossary. • Related to number of markets where adjusted net revenues from smoke-free products exceed 75% of adjusted total net revenues: excluding PMI Duty Free. World Bank report issued in 2023 is used on a comparative basis for income level classification. For definition of low- and middle-income markets, see PMI Integrated Report 2023 Glossary. • Change in combustible tobacco product shipment volume (billion units) vs. 2015 baseline is calculated based on millions of units. For definition of heated tobacco units and combustible tobacco products, see PMI Integrated Report 2023 Glossary. Combustible tobacco products shipment volume includes cigarettes and other tobacco products expressed in cigarette equivalent units. • Adjusted R&D expenditure excludes asset acquisition cost related to OtiTopic, Inc. in 2021. Total reported R&D expenditure in 2021 including these items amounted to USD 617 million. • Direct spend focuses on materials used in the manufacture of our products; it includes tobacco leaf, direct materials, and electronic devices and accessories. Data excludes Swedish Match and Vectura Fertin Pharma. • Number of factories producing smoke-free products out of total number of factories reflects the number of factories operated and owned by PMI at the end of the respective year. As of 2023, “Smoke-free products factories” is defined as manufacturing facilities producing heated tobacco units and oral nicotine products. Additionally, in 2023, PMI evolved its approach to report the number of factories based on location instead of based on plant. If a facility is in one location but has several physical areas (plants), the facility is counted as one. To provide comparability, 2022 data has been restated on the same basis. 29 30 PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries Reconciliation of Non-GAAP Measures Research & Development Expenditure by Product Category ($ in millions) / (Unaudited) 2015 2021 2022 2023 Combustible Tobacco $ 129 $ 7 $ 7 $ 4 Smoke-free incl. Wellness & Healthcare 294 609 (a) 634 705 Total PMI $ 423 $ 617 (a) $ 642 $ 709 Years Ended December 31, (a) Includes asset acquisition cost of $51 million related to OtiTopic Inc. in August 2021. Excluding this impact total PMI adjusted R&D expenditures are $566 million and for smoke-free incl. W&H $558 million Note: Sum of product categories might not foot to Total PMI due to roundings -- 15 of 16 -- Championing a Smoke-Free World 2024 First-Quarter Results April 23, 2024 -- 16 of 16 --